
[
  {
      "text": "Hello"
  },


  {
    "text": "____Demo Location Update____",
    "disabled": true

  },


  {
    "text": "Let's build a model."

  },
  {
    "text": "AKT1 phosphorylates MAPK1."

  },
  {

    "text": "EGF binds EGFR."

  },
  {
    "text": "Let's move AKT1 and MAPK1 into mitochondrion."
  },

  {
    "text": "Phosphorylated MAPK1 is active."
  },

  {
    "text": "FEN1 phosphorylates AKT1."
  },

  {
    "text": "Move all into nucleus."
  },
  {
    "text": "Move AKT1 out of nucleus."
  },

  {
    "text": "Let's highlight the downstream of AKT1."
  },

  {
    "text": "____Demo Visualization____",
    "disabled": true

  },


  {
    "text": "Let's build a model."

  },
  {
    "text": "AKT1 phosphorylates MAPK1."

  },
  {
    "text": "Let's show AKT1 on the top."
  },

  {
    "text": "Let's move phosphorylated MAPK1 to the bottom."
  },

  {
    "text": "Let's highlight the downstream of AKT1."
  },

  {
    "text": "Let's highlight the upstream of phosphorylated MAPK1."
  },

  {
    "text": "Let's show phosphorylated MAPK1 on the top."
  },
  {
    "text": "Let's move mitochondrion elements to the top."
  },
  {
    "text": "____Demo Causality____",
    "disabled": true

  },
  {
    "text": "How does BRAF affect MAPK1?"

  },
  {
    "text": "How does MAPK1 affect BRAF?"

  },
  {
    "text": "What is the path between BRAF and MAPK1?"
  },

  {
    "text": "What genes does MAPK1 phosphorylate?"
  },

  {
    "text": "What pathways affect BRAF?"
  },

  {
    "text": "What genes activate ILK?"
  },

  {
    "text": "How does KRAS activate MAPK3?"
  },
  {
    "text": "____BMEG____",
    "disabled": true

  },
  {
    "title": "Finds drugs that perform significantly better on killing cells with TP53 alterations compared to killing cells without TP53 alterations.",
    "text": "What is the drug response on cells with TP53 alterations?"

  },
  {
    "title": "Finds drugs that perform significantly better on killing cells with TP53 alterations compared to killing cells without TP53 alterations.",
    "text": "What is the drug response for cells with TP53 alterations?"

  },
  {
    "text": "What is the mutation frequency of EGFR in glioblastoma?"
  },

  {
    "text": "What is the mutation frequency of TP53 in ovarian serous cystadenocarcinoma?"
  },

  {
    "text": "Show me the mutations of BRAF in breast cancer."
  },

  {
    "text": "What are the mutations of PTEN in breast cancer?"
  },

  {
    "text": "____Misc____",
    "disabled": true

  },
  {
    "text": "What is the most likely cellular location of AKT1 and BRAF?"

  },
  {
    "title": "Finds genes that modify the function of both AKT1 and BRAF.",
    "text": "What are the common upstreams of AKT1 and BRAF?"

  },
  {
    "title": "Finds genes that modify the function of both AKT1 and BRAF.",
    "text": "Are there common upstreams of AKT1 and BRAF"
  },

  {
    "title": "Finds genes that modify the function of  AKT1, BRAF and MAPK1.",
    "text": "What are the common upstreams of AKT1, BRAF and MAPK1?"
  },

  {
    "title": "Finds genes with alterations that have significantly low overlap with the alterations of CDH1.",
    "text": "What genes are mutually exclusive with CDH1 for breast cancer?"
  },

  {
    "title": "Finds genes with alterations that have significantly low overlap with the alterations of TP53.",
    "text": "What are the mutually exclusive genes with TP53 for breast cancer?"
  },
  {
    "title": "Shows MutSig results to identify genes that were mutated more often than expected by chance.",
    "text": "What is the mutation significance of TP53 for lung cancer?"
  },
  {
    "title": "Shows MutSig results to identify genes that were mutated more often than expected by chance.",
    "text": "WWhat is the mutation significance of TP53 in ovarian serous cystadenocarcinoma?"
  },
  {
    "title": "Shows MutSig results to identify genes that were mutated more often than expected by chance.",
    "text": "What is the mutation significance of PTEN in pancreatic adenocarcinoma?"
  },
  {
    "title": "Shows MutSig results to identify genes that were mutated more often than expected by chance.",
    "text": "What is the mutation significance of BRAF in prostatic adenocarcinoma?"
  },

  {
    "text": "____Model_____",
    "disabled": true

  },
  {
    "text": "MEK phosphorylates ERK."

  },
  {

    "text": "EGF binds EGFR."

  },
  {

    "text": "EGFR bound to EGF binds GRB2."

  },
  {

    "text": "Phosphorylated ERK is active."

  },
  {

    "text": "MAP2K1 phosphorylated at S220 phosphoryates MAPK1."

  },
  {

    "text": "Active TP53 transcribes MDM2."

  },
  {

    "text": "Undo"

  },
  {

    "text": "Is phosphorylated MAPK1 always high?"

  },
  {

    "text": "Is the amount of phosphorylated MAPK1 eventually high?"

  },
  {

    "text": "Is the MAP2K1-MAPK1 complex formed?"

  },
  {

    "text": "Is the amount of FOS ever high if we increase the amount of ELK1 by 10 fold?"

  },
  {

    "text": "Does Vemurafenib decrease phosphorylated ERK in the model?"

  },
  {

    "text": "Does Selumetinib decrease JUN in the model?"

  },
  {

    "text": "How does KRAS regulate MAP2K1?"

  },
  {

    "text": "How does HRAS activate MAPK3?"

  },
  {

    "text": "Does phosphorylation at S222 activate MAP2K1?"

  },
  {

    "text": "What drugs inhibit MAP2K1?"

  },
  {

    "text": "Are there any drugs for BRAF?"

  },
  {

    "text": "Does Vemurafenib inhibit BRAF?"

  },
  {
    "text": "____TFTA_____",
    "disabled": true

  },
  {

    "text": "What are the targets of PLX-4720?"

  },
  {

    "text": "Which transcription factors regulate frizzled8?"

  },
  {

    "text": "Does TP53 target MDM2?"

  },
  {

    "text": "What are the regulators of SRF?"

  },
  {

    "text": "What transcription factors are shared by SRF, HRAS, and ELK1?"

  },
  {

    "text": "Which pathways involve TAP1 and JAK1?"

  },
  {

    "text": "What genes are in the prolactin signaling pathway?"

  }
]
